Phase 2 trial data published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023) reported mean weight reductions of up to approximately 24% over 48 weeks in adults with obesity notably higher than results seen with currently approved agents
Yet the new benefit wont help the vast majority of the 1.5 million adults in South Carolina who are classified as obese, according to data published by the South Carolina Department of Public Health
Our goal is to position your practice as a go-to destination for effective weight loss solutions, using targeted campaigns and content that speaks to your patients' needs
Medicines administration chart/prescription
Y2R is widely expressed in multiple brain regions such as the amygdala, hippocampus, cortex, thalamus, lateral septum, olfactory nuclei and striatum (Caberlotto et al., 1998
The diet that worked at 35 fails at 55